A look at the M&A and stock market pictures for full-year 2024—and the potential strategic implications for pharma and ...

It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their U.S.

We hoped industry layoffs would relent in ... Story Feb. 6 - X4 Pharmaceuticals: The rare disease biotech is laying off 43 employees—equivalent to 30% of the company’s total staffers—along ...

U.S. investors and pharmaceutical giants are increasingly looking to China for drug innovation, with nearly 30% of major pharma deals last year involving Chinese companies—up from 0% in 2019.

U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...

By fusing circular dichroism with high-resolution microspectroscopy and microscopic imaging, this cutting-edge technology is ...

Dr. Arum Han, the Texas Instruments Professor in the Department of Electrical and Computer Engineering, and his lab, created a technology named NOVAsort (Next-generation Opto-Volume-based Accurate ...

Amid the federal funding uncertainty for health and sciences, local life science leaders say this could be a moment for industry partners ... In comparison, Massachusetts-based biotech companies ...

Several members of our firm’s life sciences team were on the ground at the 43rd Annual J.P. Morgan Healthcare Conference in ...

B.well Connected Health, maker of a platform unifying patient data, picked up an additional investment from nonprofit ...